In this article we explore the discourse and prac tice of evidence-based medicine (EBM) in the context of social and cultural diversity. The article consists of 2 parts. First, we begin by defi ning EBM, describing its historical development and current ascendance in medical practice. We then note its importance in contemporary psychiatry, comparing dynamics between the United States and Canada. Secondly, we offer a constructive critique of the application of EBM and evidence-based practices in the context of ethnocultural diversity, as one consistent refl ection on the EBM literature is that it is does not adequately address issues of diversity. In doing so, we use the situation here in Canada as an extended case study, though our observations will likely be applicable in other diverse nations, such as the United States, the United Kingdom, and Australia. We critically examine the following 6 issues related to the practice of EBM in a diverse society: generalizability and transferability of evidence-based interventions; diversifying standards of evidence in EBM; strategies to address diversity in EBM research; cultural adaptations of evidence-based interventions; integrating idiographic knowledge; and, training and health service delivery. Concurrent with our critique, we offer research and practice suggestions that may address outstanding challenges vis-à-vis the practice of EBM in a diverse society. These include a need for more effectiveness research, more openness to diverse sources of knowledge, better integration of idiographic and nomothetic knowledge, and a critical approach to extrapolation and transfer of knowledge.
T he EBM movement arose out of concern that many patients were receiving ineffective treatments that were grounded in conventional practices, clinical intuition, or practitioner idiosyncrasies rather than scientifi c evidence. 1, 2 British epidemiologist Archie Cochrane was the pioneer par excellence of EBM, arguing that researchers must systematically evaluate each and every intervention through RCTs to determine their true effi cacy. 3, 4 Only those interventions shown to have signifi cant and consistent effects on outcomes through accumulated RCTs would then be labelled evidence-based. Health providers and planners could then work to make these interventions readily available. 5 Cochrane's ideas reached a wider audience through the seminal work of Canadian researchers, led by David Sackett and Gordon Guyatt at McMaster University. 6 Their work in the 1980s and 1990s solidifi ed the place of EBM in medical care. In a seminal paper, they defi ned EBM as "the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients." 1, p 71 The explicit mention of "judicious use" acknowledged that the practice of EBM meant integrating clinical expertise with the best available evidence from systematic research. In recent years, governments around the world have endorsed EBM as a desirable basis for health care services, with the rationale that, in the context of limited resources, public money will be better spent on interventions with proven effectiveness and effi cacy. Thus EBM is considered a matter of responsible community health services and prudent public policy. 7, 8 EBM became prominent in psychiatry in the 1990s, mainly through the production of practice guidelines and the adoption of specifi c interventions as EBPs. 5, 9 EBPs are psychosocial or psychopharmacological interventions deemed effi cacious after multiple RCTs and quasi-experimental studies consistently indicate positive outcomes. 10 EBPs have become infl uential across psychiatry, from the psychosocial treatment of SMIs to pharmacological interventions in child and adolescent psychiatry. Regarding the latter, a series of Canadian-based RCTs have shown the effi cacy of CBT in treating childhood anxiety disorders (for examples, see Manassis, 11 Manassis et al, 12 and Mendlowitz et al 13 ) . Other Canadian-based RCTs have shown the effi cacy of methylphenidate in the treatment of attention-defi cit hyperactivity disorder (for examples, see Hechtman, 14, 15 and Hechtman et al 16 ). These data have led to evidence-based clinical practice guidelines, 17 endorsed and disseminated by the Canadian Medical Association.
When suffi cient research has accumulated, interventions may be deemed EBPs after systematic reviews of the literature or meta-analyses, and these EBPs then may be endorsed by statutory bodies or key stakeholders working in the fi eld of health service delivery. Governmental, regulatory, and professional organizations support EBPs through dissemination of practice guidelines as well as toolkits and training. 18, 19 
EBM in Canadian Psychiatry
Although there have been endorsements of the philosophy of EBM and efforts to integrate it into training and practice, in offi cial documents Canadian organizations have preferred the less prescriptive language of guidelines. For example, the CANMAT (a not-for-profi t scientifi c and educational organization) has produced guidelines for the treatment of depression and bipolar disorder, without explicit mention of EBPs, and only infrequent mention of EBM. [19] [20] [21] [22] [23] [24] [25] [26] These CANMAT guidelines were written after a systematic review of the literature following principles of EBM, grading the evidence in favour of large placebo-controlled RCTs and meta-analyses. 27, 28 Similarly, the Canadian Psychiatric Association has produced clinical guidelines on treatment of specifi c disorders, which leave latitude to the clinician, without mention of EBPs. This situation is similar at the provincial level, with observers early on and more recently noting that Canadian jurisdictions are not identifying EBPs or providing them to their populations. [29] [30] [31] The enthusiastic embrace of EBPs in the United States may refl ect differences in the larger care system in terms of economic rationalization and standardization as strategies to address political and legal challenges to professional authority. In an era of bureaucratization and corporatization of health care, EBM has been part of efforts by the medical profession to maintain autonomy and control over clinical decision making. 32 Nevertheless, some clinicians have resisted EBM because of the sense that it provides them with limited answers to the complex situations faced in everyday clinical care. 33 The ability of the EBM perspective to address issues of diversity in mental health services is of particular importance given current efforts by the MHCC to promote the transformation of mental health care in Canada. 34 The MHCC document for a mental health strategy for Canada, entitled Toward Recovery and Well-being, 35 sets out 7 broad goals, 2 of which are especially pertinent to the concerns of this paper. Goal 3 states that "The mental health system responds to the diverse needs of all people living in Canada," 35, p 18 and Goal 6 states that "actions are informed by the best evidence based on multiple sources of knowledge, outcomes are measured, and research is advanced." p 19 Interestingly, the MHCC framework document makes no explicit reference to EBM or EBP. Throughout the document there are expressions of the importance of scientifi c research to provide evidence about what practices are effective. However, there is also recognition of multiple sources of knowledge and ways of knowing. This likely refl ects the strong infl uence of key community stakeholders in the work of the MHCC. For example, the MHCC has advisory committees, representing consumers and Aboriginal Peoples, that have emphasized the importance of lived experience and traditional knowledge as routes to understanding and promoting mental health as well as to developing and assessing effective interventions.
Social and cultural diversity pose challenges to the practice of EBM at the level of the production of knowledge and its clinical application. Given that there is now a window of opportunity for advancing mental health policy in Canada through the work of the MHCC, it is important to critically 
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Ethnocultural Diversity and EBM
The diversity of Canadian society is refl ected in variations in language, religion, ethnicity, and immigration status. 36, 37 Almost 18% of Canadians have a mother tongue other than English or French, and 18% were born outside of Canada. These fi gures are much higher in the major conurbations of Toronto, Montreal, and Vancouver. 38, 39 As in other diverse countries, some groups fare less well than others. A growing research literature suggests important inequities in access to care within the mental health system in Canada. These inequities particularly affect Aboriginal Peoples, immigrants, and some ethnocultural minorities. [40] [41] [42] [43] [44] One consistent refl ection on the EBM literature is that it is does not adequately address issues of diversity. [45] [46] [47] [48] Systematic studies needed to establish EBPs are limited for cultures other than the majority culture. 49 There is a paucity of information on optimal treatments for immigrants, refugees, or ethnocultural minorities, with few rigorous evaluations of routine or specifi c services for these populations. 50 This is also the case for Aboriginal Peoples. 51 This raises various questions about the generalizability and appropriateness of EBP for diverse populations, which will be discussed in detail in the remainder of our paper.
Generalizability and Transferability of Evidence-Based Interventions
Most participants in RCTs of psychiatric treatments, to date, have been of European descent. 52 The common assumption is that similar outcomes will be seen in ethnocultural minorities (who did not take part in the trials). However, treatment models evaluated in one population may not be effective or appropriate for another population. 46 In particular, differences in culture, biology, underlying values, and available resources may infl uence the accessibility, effi cacy, and appropriateness of mental health services and interventions in other populations. 53 RCTs often occur in specialized clinical settings, with highly selected samples of patients who are not representative of general clinical populations. 6 Narrow inclusion criteria may exclude large proportions of patients; for example, many controlled studies of SMI exclude people with SUD, even though about 50% of people with an SMI have this comorbidity. 54 Owing to other selection biases, these studies often do not refl ect the ethnocultural diversity of national populations. In recent years, researchers in the United States and the United Kingdom, have been encouraged to consider ethnocultural diversity in designing studies. 55 However, even when studies include specifi c ethnic minorities in the United States and the United Kingdom the samples may not correspond to the most common ethnocultural groups found in Canada. Moreover, the categories of group identity are themselves social, cultural, and political constructions fi rmly embedded in a specifi c locale. 56, 57 Categories of race, ethnicity, and culture that have emerged in one social-historical context cannot be consistently applied across societies. Canada has its own distinct patterns of ethnocultural diversity, refl ecting different histories of migration and confi gurations of identity, with potential infl uences on help seeking, health care use, and response to treatment. 58, 59 Further, studies conducted in highly controlled or specialized clinical settings may not refl ect the real-world experiences of people in a diverse society. For example, RCTs typically examine the effect of a single treatment on a specifi c disorder by focusing on a narrow range of outcomes (usually symptoms or level of functioning) during a limited period of time (weeks to months). 60 In reality, of course, many people with mental illness have multiple physical and mental comorbidities (including SUD, diabetes, respiratory illness, hepatic diseases, and the human immunodefi ciency virus) and will often be taking medication for a range of illnesses. 6 The practice of EBM is particularly complicated by multiple comorbidities and polypharmacy, phenomena underresearched in the EBM literature.
Finally, many of the EBPs commonly used in psychiatry were developed in the United States, where the experimental intervention is compared with treatment as usual. Treatment as usual in the United States may be quite different from treatment as usual in the publicly funded Canadian health care system. Given these differences in comparator, interventions deemed evidence-based in the United States may not be found equally effective in Canada or elsewhere.
Interventions cannot be understood independently of the social and cultural contexts in which they are developed and applied. 61
Diversifying Standards of Evidence in EBM
The production of scientifi c evidence does not occur on a level playing fi eld. Economic interests, notably the pharmaceutical industry, have exerted strong biases on the accrual of evidence, suppressing and distorting results, resulting in infl ated estimates of the effi cacy of many medications. [62] [63] [64] Concurrently, other potentially effective treatments have not received adequate evaluation, especially novel, psychosocial, or community-based treatments, which do not have the fi nancial backing of corporate interests. 65, 66 Some psychosocial interventions, such as supported employment or assertive community treatment, have been adequately evaluated through numerous government-or foundation-funded RCTs. 67 However, other promising interventions, for example, cultural competence or cultural formulation ones, have had diffi culty raising funding for evaluation, 68 perhaps owing to the current dominance of biological psychiatry 69 within wider mental health sciences.
Many proponents of EBM present an idealized view of the path of medical evidence from scientifi c research to clinical practice. 32 This view ignores all of the interests and biases that infl uence the production, interpretation, and application of knowledge, well known to students of the sociology of knowledge. EBM tends to ignore the power dynamics involved in the production of knowledge 70 -although it provides the tools to identify systematic bias in reported research studies and uncovers hidden agendas.
Critics of EBM describe it as rooted in a positivist epistemology, which eliminates subjectivity (and with it culture and context) as unmeasurable and hence meaningless. 71, 72 Recognition of the value of forms of evidence other than RCTs has come from the work of social scientists who have emphasized the importance of context in mental health and illness. There is a cogent argument that contextual factors have been downplayed in the discourse of EBM. 6, 60, 72 Underrepresentation of studies of the impact of contextual factors limits the application of EBM to reallife situations. More fundamentally, feminist, indigenous, and postcolonial scholars have challenged the dominance of science as a way of knowing and argued for ways of knowing based on alternate methods and epistemologies. [72] [73] [74] Qualitative studies often are not included in EBM reviews. 75 Although there are increasing efforts to develop ways of grading qualitative studies and including them in the deliberative process, they still tend to occupy the lowest rungs of evidence in systematic reviews. 76, 77 Qualitative forms of inquiry attend to crucial experiential and contextual factors that may be dismissed as noise in other research designs. 78 Because of the challenges posed by validity issues in transcultural research, systematic mixedmethod reviews are increasingly used to establish a baseline of the evidence available in the fi eld of transcultural health research. [79] [80] [81] Attention to these issues can produce important information about people who appear to be exceptions to the rule or outliers or nonresponders, providing crucial insight into for whom and under what conditions evidence-based interventions are most effective. Mixed-methods research may provide opportunities to build knowledge of context and refl exivity into the process of developing EBM and corresponding clinical skills.
Strategies to Address Diversity in EBM Research
The uneven production of evidence in EBM is especially severe for interventions designed specifi cally for immigrants, refugees, and ethnocultural minorities. 45, 48 Recent reviews of evidence for primary care treatment of common mental disorders for newcomers to Canada found almost no relevant studies. 50, 82 Of course, the absence of evidence for effectiveness owing to a lack of studies is not at all the same as fi ndings of a lack of effectiveness in welldesigned trials. Unfortunately, in organizing practice based on available evidence, the lack of information counts against both conventional and promising new practices, especially those specifi cally designed or tailored for ethnocultural minorities.
To address this issue, new and existing practices could be developed and refi ned in a bottom-up manner in collaboration with ethnocultural communities, and then tested for effectiveness. 68 This will produce evidence of cross-cultural applicability of interventions as well as potentially identify new strategies for intervention that may be transferrable to other cultural groups.
Although conducting systematic studies with specifi c ethnocultural groups can provide an essential complement to existing evidence, it likely will remain impractical to conduct such research with many of the smaller groups that comprise Canadian society. Moreover, even the larger ethnocultural blocs are defi ned by crude distinctions in geographic origins (for example, South Asian and Chinese), religion (for example, Moslem, Christian, and Buddhist), ethnicity, or language that ignores their great internal heterogeneity. This heterogeneity means that small trials may have limited generalizability, even within the same ethnocultural group.
A more practical strategy to address this heterogeneity would be to identify potential culture-related variables associated with treatment effectiveness and outcome. These may be chosen by their likely relation to the putative mechanisms of interventions. These variables may be biological (for example, genetic polymorphisms, diet, and environmental exposures), psychological (for example, confi gurations of identity and illness explanations), existential (for example, theism and allocentrism), or social (for example, gender roles, family structure and composition, immigration status, and exposure to discrimination or trauma). Evidence that a treatment works for subgroups of people with specifi c characteristics can then be generalized, with appropriate cautions, to individuals with similar characteristics. Decomposing culture and ethnicity in this way avoids stereotyping and can produce more generalizable knowledge. As certain cultural traits or social factors are more prevalent in specifi c ethnocultural groups, this research strategy can also increase our understanding of clinically relevant group differences. Of course, it does not capture all salient dimensions of culture, nor does it address how these dimensions interact as part of a social system. Understanding the systemic levels of culture requires other methodologies.
Cultural Adaptations of Evidence-Based Interventions
Another strategy involves adapting existing EBPs to make them more accessible and acceptable to a particular group or to optimize their effectiveness. This approach has been taken in various cultural adaptations of psychotherapeutic interventions. Adaptation can occur at various levels, ranging from cosmetic packaging of interventions to adding or deleting specifi c components to fi t cultural expectations, to the integration of culture-specifi c interventions.
In a description of the adaptation of a cognitive-behavioural intervention for children, Ngo et al 83 view cultural adaptation as a form of packaging, which does not alter the core components of the manualized intervention. The hope is that this culturally sensitive repackaging can signifi cantly increase effectiveness by improving acceptability, attractiveness, and adherence to treatment. The aim is to maintain fi delity to evidence-based treatment but increase cultural appropriateness. This approach has the advantage of convincing research funding agencies and clinicians of the scientifi c soundness of the proposed intervention because the core elements are not modifi ed. However, this form of adaptation by appropriation raises important ethical and scientifi c questions because it may foreclose discovering new mechanisms of effi cacy that depend on features of the intervention that are not equivalent to conventional therapies. 84 Adding activities (such as prayer, relaxation exercises, artistic expression, and mindfulness, borrowed from traditions like Buddhism) to interventions such as CBT cannot be considered as mere packaging. 85 These additional elements may play an essential role in enhancing effi cacy. Describing these additions as packaging introduces a bias into the production of evidence because it ascribes effi cacy to the manual-based intervention without examining the independent contribution of other culture-specifi c components, which may be part of longstanding systems of healing. 86, 87 Beyond this, the tacit assumption that previously researched EBPs in Western populations will be more effective than local, traditional, and spiritual treatments can be seen as ethnocentrism. 88 Cultural adaptation presents an opportunity to examine the convergences and divergences between contemporary interventions and healing traditions, which include novel interventions worthy of study in their own right. Adaptation then can be viewed not as repackaging but as a process of knowledge exchange. Clear indication of the value of cross-cultural knowledge exchange comes from the recent development of psychotherapeutic interventions based on Buddhist psychology, including mindfulness mediation, acceptance and commitment therapy, and compassion therapy. 89
Integrating Idiographic Knowledge
A general problem facing EBM is that RCTs produce group-level probability estimates, noting the likelihood that those in the experimental group have a better outcome than those in the control group. In other words, this methodology is useful for indicating average effects, but does not have specifi city for individuals, risking an inferential (ecological) fallacy if uncritically applied to an individual. 60 This problem of clinical inference from group means to individual outcomes is still more challenging in highly diverse societies. Groups may vary in key demographic factors such as ethnicity, age, sex, and comorbidity. No matter how complete the EBM database becomes, clinicians will still have the challenge of translating group-level statistical results obtained from clinical trials into specifi c interventions tailored to the individual patient. 90 A myriad of personal and contextual details must be considered to make this translation. EBM acknowledges the importance of such clinical judgment but remains rather weak in its development of theory and practice regarding the optimal manner to make this translation. 68 Making EBPs widely available and accessible may be an important public health intervention. However, the appropriate choice and application of EBPs for specifi c individuals requires clinical skill and judgment. 91 This requires knowledge of context that is usually obtained through close examination of an individual's lifeworld and experience.
Illness experience is deeply embedded in the lifeworld and sociocultural context of the person seeking treatment. 92, 93 Although EBM explicitly recognizes the need to attend to patients' preferences, in practice it tends to emphasize routinized, manualized, and standardized approaches to treatment. 94 Placing greater emphasis on the interpretive dimensions of EBP may mitigate the tendency toward standard one-size-fi ts-all clinical interventions. In this area, EBM can learn from the ongoing work in personcentred medicine. 61 In practice, EBM must be interpretive in orientation, bridging nomothetic or general knowledge as refl ected in the best evidence and idiographic knowledge derived from the experience of the individual patient. There are some positive examples of this process. For example, some psychosocial EBPs, such as supported employment, have mechanisms built into the intervention that ensure that idiographic knowledge is elicited and prioritized in the treatment plan. In this model, client preferences regarding employment take absolute precedence, with clinicians trained to be facilitators of clients' desires. 95 Another positive example of this integration of nomethetic and idiographic knowledge is the emerging paradigm of shared decision making, in which clinicians and patients negotiate a treatment plan from a list of options. 96 In this model, patients are given a strong voice in clinical decision making, ensuring that their preferences and values are elicited and integrated into treatment. 97 This respect for patients' values is consistent with basic principles of medical ethics. However, as shared decision making is further refi ned and developed for diverse populations, it will be essential to interrogate the hidden assumptions and potentially ethnocentric biases of this model. For example, privileging the individual decision making of the patient refl ects an individualistic ethos that may be inconsistent with normative values of familial or group decision making in certain cultures. 98 Ensuring that a culturally appropriate form of shared decision making is employed can prevent EBM from becoming a utilitarian intervention that imposes culturally dissonant values on patients at a time when they are most vulnerable.
Additional strategies to address diversity can be found in the shift to person-centred practice. Person-centred psychiatry involves a clinical approach that aims to assess both illness and health in social and cultural context. 99 Tools like the cultural formulation in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, were developed to help clinicians organize information about patients' social and cultural context relevant to diagnostic assessment and treatment. 100 However, to date, there are few studies examining the impact of such information on treatment selection, delivery, and outcome. Current efforts to develop cultural formulation interviews and measure their effect on diagnostic assessment, treatment alliance, adherence, satisfaction, and outcomes, may provide a fi rmer footing for the work of translating generic knowledge to specifi c individual context-sensitive intervention. 101, 102 
Training and Health Service Delivery
Other issues relevant to implementing EBM and EBPs for diverse populations relate to training and service delivery.
Although professional regulatory and accreditation organizations have instituted guidelines for training in cultural competence and clinical practice that include attention to social and cultural dimensions of care, to date there have been few efforts to evaluate the effects of training on practice in a range of clinical and community settings, especially related to EBP or EBM. 45, 49 To the extent that an evidence-based approach means a narrow focus on RCTs of prepackaged treatments, it can work against the client-centred and contextual approach needed for cultural competence. 103 Nonetheless, there is increased recognition of the need to document the impact of cultural competence approaches. There is good evidence that cultural competence infl uences the quality of the clinical encounter, [104] [105] [106] and there is evidence for signifi cantly greater effectiveness for psychotherapeutic interventions that attend explicitly to cultural issues. 107 Many provinces have made efforts to reinforce primary care as the main site of delivery of health care services, with secondary and tertiary care used in only the most severe cases. 108, 109 Concurrently, there have been specifi c efforts to consider how to address cultural diversity in primary mental health care. 50, 110 However, many psychosocial EBPs in psychiatry, such as supported employment and assertive community treatment, rely on an extensive backdrop of secondary and tertiary resources and specialists. These include case managers, social workers, and vocational rehabilitation specialists, as well as community-based rehabilitation and social service centres. Strengthening primary care requires an integration of some of these resources and specialists-who may have their own complex relationships to the values and practices of minority cultural communities. Such collaborative care models have been shown to reduce stigma associated with secondary and tertiary mental health services, 111 and this may benefi t ethnocultural communities that come from parts of the world where psychiatry is exclusively associated with highly stigmatized secondary and tertiary care institutions. 112 Further, the ecological approach sometimes associated with proximity primary care services may facilitate the adaptation of services to the distinct psychosocial needs of neighbourhood-based immigrants and refugee communities. 113
Conclusion
There are fundamental tensions between the EBM approach, which seeks generalizable treatments that can be used for all members of a population, and person-centred approaches, which aim to understand each individual in context. However, there may be ways to integrate the strengths of EBM methods with person-centred psychiatry, to develop an approach to clinical practice that is at once humane, responsive to social context, and well-grounded in empirical research. Some psychosocial EBPs, such as supported employment and assertive community treatment, have made great strides in this regard, integrating nomothetic and idiographic to advance recovery. The paradigm of shared decision making also offers a fresh and promising approach to such integration. 
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